Publications
84
Citations
1,760
Est. group size
~45
Recurring co-author estimate
Active years
17
Publishing since 2010
Joseph S. Bednash studies lung injury and severe respiratory illness, including acute respiratory distress syndrome (ARDS) and COVID-19, examining how immune cells, inflammation, and cell-signaling molecules (such as tRNA fragments and mitochondrial proteins) contribute to disease and organ damage. A related line of work tracks how SARS-CoV-2 variants evolve to escape immune defenses and change infectivity, alongside clinical trials testing potential treatments for COVID-19-related lung failure. This research combines laboratory molecular biology with clinical and translational studies in critically ill patients.
Publication output has grown substantially over the last decade, rising from just a few papers per year around 2017-2019 to over 20 in 2024, with continued high activity in 2025 and early 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Heterogeneous causes of acute respiratory distress syndrome correlate with distinct peripheral polyunsaturated fatty acid metabolites
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- <i>Pseudomonas aeruginosa-</i> mediated cardiac dysfunction is driven by extracellular vesicles released during infection
mBio · 2026
- Airspace miR-146a levels in ventilated patients decrease with age and correlate with mortality
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants
mBio · 2025
- Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability
Journal of Virology · 2025
- Plasma proteomic profiles correlate with organ dysfunction in COVID‐19 ARDS
Physiological Reports · 2025
- Transfer RNA (tRNA) Fragments, Regulated by the tRNA Methyltransferase TRMT1, Regulate Cytokine Responses and Cell Death During Lung Injury
American Journal of Respiratory and Critical Care Medicine · 2025
- H. Influenzae Type B Infection Stabilizes an Immune Suppressor Protein, FBXO24
American Journal of Respiratory and Critical Care Medicine · 2025
- TRMT1 Methyltransferase Activity Preserves Inflammasome Function
American Journal of Respiratory and Critical Care Medicine · 2025
- Secreted mitochondrial aspartyl‐ <scp>tRNA</scp> synthetase ( <scp>DARS2</scp> ) regulates <scp>TNFα</scp> signaling
Physiological Reports · 2025
- Addition of I.V. Citicoline to Standard of Care in Hospitalized COVID Patients with Acute Hypoxemic Respiratory Failure or ARDS: A Block-Randomized, Double-Blinded, Placebo-Controlled, Phase 1/2 Superiority Trial
SSRN Electronic Journal · 2025
- Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
Cell · 2024
- Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
Cell Reports · 2024
- Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
mBio · 2024
- Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19
Frontiers in Immunology · 2024
- bioRxiv (Cold Spring Harbor Laboratory)×11
- American Journal of Respiratory and Critical Care Medicine×5
- Frontiers in Immunology×4
- mBio×3
- The Journal of Immunology×3
- Jaffar A. Al‐Tawfiq
Medicine · Indiana University
- Jingyou Yu
Medicine · The Ohio State University
- Hadi M. Yassine
Medicine · Indiana University
- Cong Zeng
Medicine · The Ohio State University
- John P. Evans
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile